Abella, Mario V.
HRN: 25-35-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/25/2024
07/02/2024
IV
1.5gms
Q6
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes